Aignostics的封面图片
Aignostics

Aignostics

软件开发

Berlin,Berlin 8,036 位关注者

AI-powered precision diagnostics for pathology

关于我们

Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.

网站
https://www.aignostics.com
所属行业
软件开发
规模
51-200 人
总部
Berlin,Berlin
类型
私人持股
创立
2018
领域
artificial intelligence、pathology、digital pathology、oncology、immuno-oncology、auto immune disease、neurodegenerative disease、improving medicine、companion diagnostics、precision medicine、solutions、R&D、computational pathology、predictive、deep learning、software engineering、translational research、target identification、healthcare和biomarkers

地点

Aignostics员工

动态

相似主页

查看职位

融资

Aignostics 共 5 轮

上一轮

B 轮

US$34,000,000.00

Crunchbase 上查看更多信息